Higher risk due to health condition

Protocols outlined for HIV-COV: a study of people living with HIV following COVID-19 vaccination

CITF-funded HIV-COV, led by Dr. Aslam Anis from the University of British Columbia, has published the protocols for its pan-Canadian study of people living with HIV who have received, or plan to receive, a COVID-19 vaccine in BMJ Open. The protocol allows for the assessment of how these people’s compromised immune systems respond to [...]

2021-12-20T15:15:05-05:00December 20, 2021|Higher risk due to health condition|

Solid organ transplant recipients mount weaker T cell responses to mRNA vaccines than they do to SARS-CoV-2 infections

An article published in the Journal of Infectious Diseases by CITF-funded researcher Dr. Deepali Kumar at the University of Toronto evaluated T cell responses in 50 solid organ transplant recipients (SOTR) who demonstrated prior COVID-19 infection. Their findings suggest that even immunocompromised individuals are capable of mounting robust T cell responses following exposure to [...]

2021-11-30T12:53:48-05:00November 29, 2021|Higher risk due to health condition|

Antibody responses to COVID-19 vaccines in people living with HIV

Researchers Drs. Zabrina Brumme and Mark Brockman from the BC Centre for Excellence in HIV/AIDS and Simon Fraser University have determined that antibody responses following one COVID-19 vaccine dose are modestly lower in people living with HIV compared to individuals without HIV. However, they report that the discrepancy disappears after the second dose. These [...]

2021-10-12T15:37:21-04:00October 12, 2021|Higher risk due to health condition|
Go to Top